Artia Global Partners LP Portfolio Holdings

Artia Global Partners LP

  • $631 Billion
  • Q3 2025

Artia Global Partners LP has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $631 Billion distributed in 51 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Insmed Inc with a value of $105B, Argenx Se with a value of $57.8B, Soleno Therapeutics Inc with a value of $45.4B, Verona Pharma PLC with a value of $40.4B, and Uni Qure N.V. with a value of $38.5B.

Examining the 13F form we can see an increase of $215B in the current position value, from $416B to 631B.

Artia Global Partners LP is based out at Miami, FL

Below you can find more details about Artia Global Partners LP portfolio as well as his latest detailed transactions.

Portfolio value $631 Billion
Healthcare: $519 Billion
ETFs: $24.8 Billion
Financial Services: $1.56 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$26.2B
$105 Billion 16.71% of portfolio
732,212
Q3 2025 Reduced 2.72%
$50.2B
$57.8 Billion 9.16% of portfolio
78,311
Q2 2025 Added 592.34%
Soleno Therapeutics Inc
-
$45.4 Billion 7.2% of portfolio
-
Q3 2025 Added 35.95%
$6.52B
$40.4 Billion 6.41% of portfolio
379,004
Q3 2025 Reduced 58.99%
$1.4B
$38.5 Billion 6.1% of portfolio
658,839
Q3 2025 New
$4.4B
$27.9 Billion 4.43% of portfolio
296,750
Q2 2025 Reduced 30.12%
$0
$24.8 Billion 3.92% of portfolio
537,372
Q3 2025 New
$971B
$21.9 Billion 3.47% of portfolio
28,700
Q3 2025 Reduced 6.51%
$111B
$21.6 Billion 3.42% of portfolio
55,100
Q3 2025 Added 1,152.27%
Abivax Sa
-
$19.1 Billion 3.03% of portfolio
-
Q3 2025 New
$661M
$18.3 Billion 2.9% of portfolio
1,999,702
Q3 2025 Added 52.43%
$147B
$17.9 Billion 2.84% of portfolio
183,200
Q3 2025 Added 18.04%
$55.3B
$15.8 Billion 2.5% of portfolio
34,570
Q3 2025 Added 64.85%
$15.6B
$15.6 Billion 2.47% of portfolio
81,717
Q2 2025 Added 44.08%
$277B
$14.6 Billion 2.32% of portfolio
190,752
Q2 2023 Added 86.45%
$404M
$8.95 Billion 1.42% of portfolio
628,367
Q3 2025 Added 98.41%
-
$5.54 Billion 0.88% of portfolio
-
Q3 2025 Added 613.2%
$5.94B
$4.87 Billion 0.77% of portfolio
104,190
Q1 2025 Reduced 63.34%
$3.69B
$4.8 Billion 0.76% of portfolio
110,100
Q3 2025 Added 218.21%
Dianthus Therapeutics Inc
-
$4.28 Billion 0.68% of portfolio
-
Q3 2025 New
$10.2B
$3.94 Billion 0.62% of portfolio
60,176
Q3 2025 New
$3.05B
$3.84 Billion 0.61% of portfolio
146,179
Q3 2025 Added 51.51%
$1.95B
$3.59 Billion 0.57% of portfolio
96,285
Q3 2025 Reduced 23.76%
$414B
$3.36 Billion 0.53% of portfolio
14,500
Q2 2025 New
Nektar Therapeutics
-
$3.3 Billion 0.52% of portfolio
-
Q3 2025 New
$2.6B
$3.23 Billion 0.51% of portfolio
133,291
Q3 2025 New
$11.4B
$2.43 Billion 0.39% of portfolio
12,240
Q2 2025 Added 64.52%
Mineralys Therapeutics Inc
-
$2.15 Billion 0.34% of portfolio
-
Q3 2025 Added 37.71%
$21.2B
$2.1 Billion 0.33% of portfolio
5,000
Q1 2025 New
$4.5B
$1.97 Billion 0.31% of portfolio
54,515
Q4 2024 New
$2.32B
$1.94 Billion 0.31% of portfolio
64,502
Q3 2025 Added 54.2%
Rapport Therapeutics Inc
-
$1.92 Billion 0.3% of portfolio
-
Q3 2025 New
$875M
$1.65 Billion 0.26% of portfolio
141,061
Q3 2025 New
$2.54B
$1.61 Billion 0.25% of portfolio
40,000
Q1 2024 New
$2.72B
$1.56 Billion 0.25% of portfolio
33,200
Q3 2025 New
$4.15B
$1.52 Billion 0.24% of portfolio
22,951
Q2 2025 Reduced 93.13%
Biohaven LTD
-
$1.2 Billion 0.19% of portfolio
-
Q2 2025 New
Brightspring Health Svcs Inc
-
$1.23 Billion 0.19% of portfolio
-
Q3 2025 New
Kiniksa Pharmaceuticals Intl
-
$1.13 Billion 0.18% of portfolio
-
Q2 2025 New
$9.84B
$1.06 Billion 0.17% of portfolio
20,400
Q3 2025 New
$227M
$979 Million 0.16% of portfolio
475,361
Q2 2025 Added 12.82%
$1.65B
$865 Million 0.14% of portfolio
44,900
Q3 2025 Sold Out
$2.21B
$739 Million 0.12% of portfolio
30,900
Q1 2025 New
$9.69B
$615 Million 0.1% of portfolio
23,800
Q3 2025 New
$328M
$506 Million 0.08% of portfolio
41,555
Q3 2025 New
$53.2M
$269 Million 0.04% of portfolio
372,276
Q3 2025 New
$102M
$210 Million 0.03% of portfolio
71,029
Q3 2025 New

Summary

  • Portfolio
  • No. of Stocks 51
  • Current Value $631 Billion
  • Prior Value $416 Billion
  • Filing
  • Period Q3 2025
  • Filing Date November 14, 2025
  • Form Type 13F-HR/A
  • Activity in Q3 2025
  • New Purchases 17 stocks
  • Additional Purchases 11 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 4 stocks
Track This Portfolio

Track Artia Global Partners LP Portfolio

Follow Artia Global Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artia Global Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Artia Global Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email